Andrew Levin
Listed on 8 Form D filings across 7+ issuers
· Director
Associated issuers
- Climb Bio, Inc. CIK 1768446 · MA
- Slate Medicines, Inc. CIK 2117806 · MA
- Solstice Oncology, Inc. CIK 2116600 · MA
- Lonestar Medicines, Inc. CIK 2111460 · MA
- Imbria Pharmaceuticals, Inc. CIK 1745672 · MA
- Superluminal Medicines, Inc. CIK 1989478 · MA
- Pahr Therapeutics, Inc. CIK 2077159 · MA
Filings (8)
-
Climb Bio, Inc.D · May 4, 2026 · MA · Biotechnology$110.1MView filing →
-
Slate Medicines, Inc.D · Mar 11, 2026 · MA · Pharmaceuticals$130MView filing →
-
Solstice Oncology, Inc.D · Mar 9, 2026 · MA · Biotechnology$298.4MView filing →
-
Lonestar Medicines, Inc.D · Feb 23, 2026 · MA · Biotechnology$45MView filing →
-
Imbria Pharmaceuticals, Inc.D · Dec 16, 2025 · MA · Biotechnology$144.2MView filing →
-
Superluminal Medicines, Inc.D · Aug 26, 2025 · MA · Biotechnology$5MView filing →
-
Pahr Therapeutics, Inc.D · Jul 18, 2025 · MA · Biotechnology$14MView filing →
-
Imbria Pharmaceuticals, Inc.D · Apr 1, 2025 · MA · Biotechnology$124.2MView filing →